Literature DB >> 28169991

A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.

Ayesha S Khan1, Daniel E Frigo1,2.   

Abstract

The 5'-AMP-activated protein kinase (AMPK) is a master regulator of cellular homeostasis. Despite AMPK's known function in physiology, its role in pathological processes such as prostate cancer is enigmatic. However, emerging evidence is now beginning to decode the paradoxical role of AMPK in cancer and, therefore, inform clinicians if - and how - AMPK could be therapeutically targeted. Spatiotemporal regulation of AMPK complexes could be one of the mechanisms that governs this kinase's role in cancer. We hypothesize that different upstream stimuli will activate select subcellular AMPK complexes. This hypothesis is supported by the distinct subcellular locations of the various AMPK subunits. Each of these unique AMPK complexes regulates discrete downstream processes that can be tumour suppressive or oncogenic. AMPK's final biological output is then determined by the weighted net function of these downstream signalling events, influenced by additional prostate-specific signalling.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28169991      PMCID: PMC5672799          DOI: 10.1038/nrurol.2016.272

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  307 in total

1.  Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization.

Authors:  S M Warden; C Richardson; J O'Donnell; D Stapleton; B E Kemp; L A Witters
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation.

Authors:  Z P Chen; G K McConell; B J Michell; R J Snow; B J Canny; B E Kemp
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-11       Impact factor: 4.310

3.  Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors.

Authors:  W Yang; Y H Hong; X Q Shen; C Frankowski; H S Camp; T Leff
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

4.  beta-subunits of Snf1 kinase are required for kinase function and substrate definition.

Authors:  M C Schmidt; R R McCartney
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

5.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

6.  Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

Authors:  M Y El-Mir; V Nogueira; E Fontaine; N Avéret; M Rigoulet; X Leverve
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

7.  Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system.

Authors:  A M Turnley; D Stapleton; R J Mann; L A Witters; B E Kemp; P F Bartlett
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

8.  5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.

Authors:  E J Kurth-Kraczek; M F Hirshman; L J Goodyear; W W Winder
Journal:  Diabetes       Date:  1999-08       Impact factor: 9.461

9.  Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.

Authors:  I Leclerc; C Lenzner; L Gourdon; S Vaulont; A Kahn; B Viollet
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

10.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.

Authors:  A S Marsin; L Bertrand; M H Rider; J Deprez; C Beauloye; M F Vincent; G Van den Berghe; D Carling; L Hue
Journal:  Curr Biol       Date:  2000-10-19       Impact factor: 10.834

View more
  25 in total

Review 1.  The pervasiveness of macropinocytosis in oncological malignancies.

Authors:  Cosimo Commisso
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-04       Impact factor: 6.237

Review 2.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

3.  Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress.

Authors:  Yue Zong; Chen-Song Zhang; Mengqi Li; Wen Wang; Zhichao Wang; Simon A Hawley; Teng Ma; Jin-Wei Feng; Xiao Tian; Qu Qi; Yu-Qing Wu; Cixiong Zhang; Zhiyun Ye; Shu-Yong Lin; Hai-Long Piao; D Grahame Hardie; Sheng-Cai Lin
Journal:  Cell Res       Date:  2019-04-04       Impact factor: 25.617

4.  PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells.

Authors:  Seong M Kim; Tricia T Nguyen; Archna Ravi; Peter Kubiniok; Brendan T Finicle; Vaishali Jayashankar; Leonel Malacrida; Jue Hou; Jane Robertson; Dong Gao; Jonathan Chernoff; Michelle A Digman; Eric O Potma; Bruce J Tromberg; Pierre Thibault; Aimee L Edinger
Journal:  Cancer Discov       Date:  2018-03-23       Impact factor: 39.397

Review 5.  Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

Authors:  Giorgia Zadra; Massimo Loda
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

Review 6.  Regulation and role of CAMKK2 in prostate cancer.

Authors:  Thomas L Pulliam; Pavithr Goli; Dominik Awad; Chenchu Lin; Sandi R Wilkenfeld; Daniel E Frigo
Journal:  Nat Rev Urol       Date:  2022-04-26       Impact factor: 14.432

7.  Starving PTEN-deficient prostate cancer cells thrive under nutrient stress by scavenging corpses for their supper.

Authors:  Vaishali Jayashankar; Brendan T Finicle; Aimee L Edinger
Journal:  Mol Cell Oncol       Date:  2018-08-17

8.  SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.

Authors:  ShuYan Liu; Xiao Li; ZhaoMin Lin; Le Su; Shan Yan; BaoXiang Zhao; JunYing Miao
Journal:  Cancer Lett       Date:  2017-12-13       Impact factor: 8.679

9.  The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models.

Authors:  Clara Lemos; Volker K Schulze; Simon J Baumgart; Ekaterina Nevedomskaya; Tobias Heinrich; Julien Lefranc; Benjamin Bader; Clara D Christ; Hans Briem; Lara P Kuhnke; Simon J Holton; Ulf Bömer; Philip Lienau; Franz von Nussbaum; Carl F Nising; Marcus Bauser; Andrea Hägebarth; Dominik Mumberg; Bernard Haendler
Journal:  Cell Oncol (Dordr)       Date:  2021-01-25       Impact factor: 6.730

Review 10.  Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?

Authors:  Laura A Sena; Samuel R Denmeade
Journal:  Cancer Res       Date:  2021-06-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.